Setmelanotide
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
Rhythm · Phase 3 · Completed · Enrollment 12
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Setmelanotide: PPL Group | n/r | n/r | n/r | n/r |
| Setmelanotide: BBS Group | n/r | n/r | n/r | n/r |
Not shown
- Setmelanotide: PPL Group: endpoint not reported
- Setmelanotide: BBS Group: endpoint not reported